脑部放疗，上午比下午敏感许多！% b6 \, p! k3 x$ ~6 c
$ Q9 o# S" J0 N- H# H% h9 v& F2 q+ b& c/ Z1 G6 s& j2 A
Cancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.
- Y- Y2 h7 P2 b+ I: O7 DGamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?1 z2 M- `; p! C/ U- R
Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.8 o3 N& `8 S' O% u; L( `
SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.$ f. f! b( I( v+ G2 z
( D( v* T3 l- ?& B( g) R. a
Abstract" ?" E) V" F. J% _* f% B+ n
BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.8 \$ j+ `5 U2 Z% b
6 ]5 p d1 b O4 h
METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.( i M' ?& P7 \( t5 ]" o+ z$ [' b
7 t: W8 G, W- a M: \8 aRESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).- z& F1 A) O3 X! Q! a
) z. i- V9 z1 j; O) d
CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series. p& j7 t5 b# I$ u9 R' m2 T$ K( y9 c9 a
+ J- T/ m5 ], @) x( ?2 i& J |
显身卡
